Literature DB >> 15812910

Animal models of epidermolysis bullosa--targets for gene therapy.

Qiu-Jie Jiang1, Jouni Uitto.   

Abstract

Mesh：

Year:  2005        PMID： 15812910     DOI： 10.1111/j.0022-202X.2005.23652.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  7 in total

1.  A direct method to determine the strength of the dermal-epidermal junction in a mouse model for epidermolysis bullosa.

Authors:  Thomas J Sproule; Derry C Roopenian; John P Sundberg
Journal:  Exp Dermatol       Date:  2012-04-16       Impact factor: 3.960

Review 2.  Laminin 332 in junctional epidermolysis bullosa.

Authors:  Dimitra Kiritsi; Cristina Has; Leena Bruckner-Tuderman
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

Review 3.  Novel molecular therapies for heritable skin disorders.

Authors:  Jouni Uitto; Angela M Christiano; W H Irwin McLean; John A McGrath
Journal:  J Invest Dermatol       Date:  2011-12-08       Impact factor: 8.551

Review 4.  Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise.

Authors:  Jean Christopher Chamcheu; Gary S Wood; Imtiaz A Siddiqui; Deeba N Syed; Vaqar M Adhami; Joyce M Teng; Hasan Mukhtar
Journal:  Exp Dermatol       Date:  2012-07       Impact factor: 3.960

5.  Spontaneous KRT5 Gene Mutation in Rhesus Macaques (Macaca mulatta): A Novel Nonhuman Primate Model of Epidermolysis Bullosa Simplex.

Authors:  Amanda L Johnson; Samuel M Peterson; Margaret M L Terry; Betsy Ferguson; Lois M Colgin; Anne D Lewis
Journal:  Vet Pathol       Date:  2020-02-25       Impact factor: 2.221

Review 6.  Epidermolysis bullosa with pyloric atresia.

Authors:  Hye Jin Chung; Jouni Uitto
Journal:  Dermatol Clin       Date:  2010-01       Impact factor: 3.478

Review 7.  Progress in heritable skin diseases: translational implications of mutation analysis and prospects of molecular therapies*.

Authors:  Jouni Uitto
Journal:  Acta Derm Venereol       Date:  2009       Impact factor: 4.437
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.